ウシ胎児血清市場：用途別、エンドユーザー別、地域別

ウシ胎児血清市場は、2024年には18億6,000万米ドルと推定され、2031年には45億4,000万米ドルに達すると予測され、2024年から2031年までのCAGRは13.6%です。

図：ウシ胎児血清の市場シェア (%)、地域別、2024年

ウシ胎児血清は、科学研究や様々な医療プロセスで使用される重要な細胞培養培地サプリメントです。これは、妊娠6ヶ月頃に屠殺された妊娠牛から採取された胎児血液から得られた胎児血液細胞に由来します。ウシ胎児血清 (FBS) には、細胞の生存、成長、増殖に不可欠な様々な成長因子、タンパク質、付着因子、ビタミンが含まれています。バイオ医薬品への需要の増加と、細胞を用いた研究への注目の高まりが、ウシ胎児血清市場の世界の成長を牽引しています。

市場力学：

世界のウシ胎児血清市場の成長は、バイオ医薬品の需要増加とライフサイエンス産業における研究活動の活発化によって牽引されています。バイオ医薬品の生産は、最適な細胞培養条件の育成と維持のためにウシ胎児血清に大きく依存しています。慢性疾患の有病率の増加は、ウシ胎児血清を利用した広範な研究活動を必要とする新薬開発の需要を促進しています。しかしながら、畜産における価格変動や動物福祉慣行に関する倫理的懸念は、市場の成長を妨げる可能性があります。また、無血清およびゼノフリー細胞培養培地へのシフトは、ウシ胎児血清市場に課題を提示します。しかしながら、個別化医療、再生療法、幹細胞研究への注目の高まりは、予測期間中に大きな成長機会をもたらすと期待されています。

当研究の主な特徴

当レポートでは、世界のウシ胎児血清市場を詳細に分析し、2023年を基準年とした予測期間 (2024-2031年) の市場規模および複合年間成長率 (CAGR%) を掲載しています。

また、さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案のマトリックスについて説明しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。

世界のウシ胎児血清市場における主要企業プロファイルを、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいて掲載しています。

主な企業は、Merck KGaA、Thermo Fisher Scientific Inc.、HiMedia Laboratories、Bio-Techne、PAN-Biotech、Atlas Biologicals, Inc.、Rocky Mountain Biologicals、Cytiva、Sartorius AG、SeraCare Life Sciencesなどです。

このレポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関して、情報に基づいた意思決定を行うことができます。

当レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。

利害関係者は、世界のウシ胎児血清市場を分析する際に使用される様々な戦略マトリックスを通じて意思決定を容易にすることができます。

目次

第1章 分析目的と前提条件

• 分析目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 市場力学・規制・動向の分析

• 市場力学
• 影響分析
• 主なハイライト
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• Porterの分析
• 企業合併・買収 (M&A) のシナリオ
• 市場動向

第4章 世界のウシ胎児血清市場：用途別、2019～2031年 (10億米ドル)

• 創薬
• 体外受精
• ワクチン製造
• 細胞ベース研究
• 診断
• その他

第5章 世界のウシ胎児血清市場：エンドユーザー別、2019～2031年 (10億米ドル)

• 製薬・バイオテクノロジー企業
• CRO (医薬品開発業務受託機関)
• 学術研究機関
• その他

第6章 世界のウシ胎児血清市場：地域別、2019～2031年 (10億米ドル)

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第7章 競合情勢

• Merck KGaA
• Thermo Fisher Scientific Inc.
• HiMedia Laboratories
• Bio-Techne
• PAN-Biotech
• Atlas Biologicals, Inc.
• Rocky Mountain Biologicals
• Cytiva
• Sartorius AG
• SeraCare Life Sciences

第8章 アナリストの提言

• 「運命の輪」
• アナリストの見解
• Coherent Opportunity Map (COM)

第9章 参考文献と調査手法

• 参考文献
• 分析手法
• Coherent Market Insightsについて

The fetal bovine serum market is estimated to be valued at USD 1.86 Bn in 2024 and is expected to reach USD 4.54 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.6% from 2024 to 2031.

Figure. Fetal Bovine Serum Market Share (%), By Region, 2024

Fetal bovine serum is an important cell culture media supplement used in scientific research and various medical processes. It is derived from fetal blood cells obtained from fetal blood collected from slaughtered pregnant cattle around 6 months of gestation. Fetal bovine serum (FBS) contains various growth factors, proteins, attachment factors, and vitamins essential for cell survival, growth, and proliferation. The increasing demand for biopharmaceuticals and rising focus on cell-based research is driving the growth of the fetal bovine serum market globally.

Market Dynamics:

The global fetal bovine serum market growth is driven by the rising demand for biopharmaceuticals and increasing research activities in life science industries. Biopharmaceutical production heavily relies on fetal bovine serum for growing and maintaining optimal cell culture conditions. Rising prevalence of chronic diseases is propelling the demand for new drug development which requires extensive research activities utilizing fetal bovine serum. However, price fluctuations in cattle farming and ethical concerns regarding animal welfare practices could hamper the market growth. Also, a shift towards serum-free and xeno-free cell culture mediums presents challenges to the fetal bovine serum market. Nonetheless, the growing focus on personalized medicine, regenerative therapies, and stem cell research are expected to present significant growth opportunities over the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global fetal bovine serum market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global fetal bovine serum market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific Inc., HiMedia Laboratories, Bio-Techne, PAN-Biotech, Atlas Biologicals, Inc., Rocky Mountain Biologicals, Cytiva, Sartorius AG, and SeraCare Life Sciences

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global fetal bovine serum market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fetal bovine serum market

Market Segmentation

• Application Insights (Revenue, USD Bn, 2019 - 2031)
  • Drug Discovery
  • In-vitro Fertilization
  • Vaccine Production
  • Cell-based Research
  • Diagnosis
  • Others
• End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CRO)
  • Academic And Research Institutes
  • Others
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • HiMedia Laboratories
  • Bio-Techne
  • PAN-Biotech
  • Atlas Biologicals, Inc.
  • Rocky Mountain Biologicals
  • Cytiva
  • Sartorius AG
  • SeraCare Life Sciences

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Fetal Bovine Serum Market, By Application
  • Fetal Bovine Serum Market, By End User
  • Fetal Bovine Serum Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Market Trends

4. Global Fetal Bovine Serum Market, By Application, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Drug Discovery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• In-vitro Fertilization
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Vaccine Production
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Cell-based Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Diagnosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Fetal Bovine Serum Market, By End User, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Pharmaceutical & Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Contract Research Organizations (CRO)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Academic And Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Fetal Bovine Serum Market, By Region, 2019 - 2031, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

7. Competitive Landscape

• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• HiMedia Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Techne
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• PAN-Biotech
• Atlas Biologicals, Inc.
• Rocky Mountain Biologicals
• Cytiva
• Sartorius AG
• SeraCare Life Sciences

8. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

9. References and Research Methodology

• References
• Research Methodology
• About us